Ben Switzer

Medical Oncologist @RoswellPark | @ClevelandClinic IMRP Grad | #ImmunoOncology enthusiast by day | Coffee roaster by night | RT≠med rec or endorsement

[Myriam Chalabi @MyriamChalabi]

About the smile: the standing ovation also meant that people saw what I knew: behind every one of these bars is a patient. I know every name and have seen almost everyone. I know their stories and their children. And I believe many are cured because of this. #ESMO22 #ChalabiPlot

[Keiran Smalley @LabSmalley]

Out today! Our editorial discussing spatial bio markers that are predictive of PD1 responses in melanoma! @CR_AACR @MoffittNews https://t.co/r9OJIaLxqr

[Roswell Park @RoswellPark]

More than 30 teams of Roswell Park specialists were selected to present findings at #AACR22. The findings include research on new cancer drugs and new uses for beta-blockers. https://t.co/qOQvXUVGS4

[Ben Switzer @BenSwitzerDO]

Taking a long pause after hearing this news. An eternal legacy built through a life cut far too short.
🙏“The idea that some lives matter less is the root of all that is wrong with the world.”🙏

[Partners In Health @PIH]

Partners In Health announced that its founder, Dr. Paul Farmer, unexpectedly passed away today in his sleep while in Rwanda.

Dr. Farmer was 62 years old. He is survived by his wife, Didi Bertrand Farmer, and their three children.

1/🧵

[Ben Switzer @BenSwitzerDO]

One million thanks to @JCOOP_ASCO for this opportunity, to the stellar @RoswellPark #melanoma multidisciplinary team of co-authors including @PuzanovIgor, and to @FunchainMD for igniting my passion in this field through a surplus of mentorship, humor, and snacks 😋.

[Ben Switzer @BenSwitzerDO]

It’s a great feeling to achieve the long-standing goal of first authorship under the guidance and seniority of one of my biggest role models, @ErnstoffMarc. https://t.co/awjrEvJRjg.

[Ben Switzer @BenSwitzerDO]

@FunchainMD Really feeling this lately. Just bought this for my fellow workroom 💪💕👊https://t.co/CFkWIOYlKL

[Ben Switzer @BenSwitzerDO]

Honored for the opportunity to collaborate w/ @jitcancer and this aspirational group of immuno-oncology thought leaders to address key topics for patients on ICI through the pandemic. Extra 🙌 to @TurajlicLab & her incredible efforts w/ the #CAPTUREstudy. https://t.co/Q4ZdnMwmZc

[Ben Switzer @BenSwitzerDO]

Honored to join this collaboration and add to the discussion of utilizing biomarkers as a means of keeping immune checkpoint inhibitors in check. Stay tuned, as the leaders of this project have some phenomenal works in the pipeline. #JITC

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis @PuzanovIgor @BenSwitzerDO @ankitakap https://t.co/iDCePxeO6u

[Joseph Sleiman, MD, FACP @JosephHabibi_MD]

Happy to share our #BacktoBedside @acgme funded project, a core part of my #IMProud experience ♥️

"Teaching residents how to Break Bad News (BBN): Piloting a resident-led curriculum and feedback ⓣⓐⓢⓚ ⓕⓞⓡⓒⓔ as a proof-of-concept study" @STEL_BMJ

https://t.co/xWFB8kE7Gb

[Ben Switzer @BenSwitzerDO]

Thrilled to simultaneously publish into @JOP_ASCO while presenting our work at #ASCOQLTY19 today! Thanks for collaboration from @CCF_IMCHIEFS and mentorship from @DaveHarrisMD towards our project examining initiatives to improve code status documentation.
https://t.co/mOJLklHEqY